Strengthening working capital position
Filed with ASX · · 2 pages · English
Epsilon Healthcare Limited (“EPN” or the “Company”) provides the following shareholder update in relation to its reinstatement of quotation on the official list of the Australian Securities Exchange (“ASX”). To strengthen the Company’s working capital position, Managing Director, Peter Giannopoulos has provided a $2,000,000 loan facility to EPN and each of the directors have agreed the deferral of
Epsilon Healthcare Limited on 6ix
Earlier from Epsilon Healthcare
- Half Yearly Report and Accounts
- Long Term Suspended Entities
- Suspension from Official Quotation - Annual Listing Fees
- Strategic $6.7m Sale and Leaseback of Southport Property
- Extraordinary General Meeting - CEO & MD Update
Later from Epsilon Healthcare
- Pre-reinstatement Disclosure
- Reinstatement to Quotation
- Quarterly Activities/Appendix 4C Cash Flow Report
- Epsilon Pharma signs manufacturing agreement with Puro NZ
- Preliminary Final Report
Follow Epsilon Healthcare into a list and get an email when it puts out news.
Follow Epsilon Healthcare